TrialClinical pharmacokinetics2023

Justifying Ribociclib Dose in Patients with Advanced Breast Cancer with Renal Impairment Based on PK, Safety, and Efficacy Data: An Innovative Approach Integrating Data from a Dedicated Renal Impairment Study and Oncology Clinical Trials.

Yan Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.